[go: up one dir, main page]

EA200200643A1 - ПИРИДО[2,3-d]ПИРИМИДИН-2,7-ДИАМИНОВЫЕ ИНГИБИТОРЫ КИНАЗ - Google Patents

ПИРИДО[2,3-d]ПИРИМИДИН-2,7-ДИАМИНОВЫЕ ИНГИБИТОРЫ КИНАЗ

Info

Publication number
EA200200643A1
EA200200643A1 EA200200643A EA200200643A EA200200643A1 EA 200200643 A1 EA200200643 A1 EA 200200643A1 EA 200200643 A EA200200643 A EA 200200643A EA 200200643 A EA200200643 A EA 200200643A EA 200200643 A1 EA200200643 A1 EA 200200643A1
Authority
EA
Eurasian Patent Office
Prior art keywords
substituted lower
nrr
cor
compounds
porr
Prior art date
Application number
EA200200643A
Other languages
English (en)
Russian (ru)
Inventor
Ричард Джон Бут
Эллен Майра Добрусин
Вэйра Прэйсэд Венкэйта Нэйджендра Джосьюла
Деннис Джозеф Макнэймара
Питер Лоуренс Тугуд
Original Assignee
Уорнер-Ламберт Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Уорнер-Ламберт Компани filed Critical Уорнер-Ламберт Компани
Publication of EA200200643A1 publication Critical patent/EA200200643A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Enzymes And Modification Thereof (AREA)
EA200200643A 2000-01-25 2001-01-23 ПИРИДО[2,3-d]ПИРИМИДИН-2,7-ДИАМИНОВЫЕ ИНГИБИТОРЫ КИНАЗ EA200200643A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17826100P 2000-01-25 2000-01-25
PCT/IB2001/000069 WO2001055147A1 (en) 2000-01-25 2001-01-23 PYRIDO[2,3-d]PYRIMIDINE-2,7-DIAMINE KINASE INHIBITORS

Publications (1)

Publication Number Publication Date
EA200200643A1 true EA200200643A1 (ru) 2002-12-26

Family

ID=22651853

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200643A EA200200643A1 (ru) 2000-01-25 2001-01-23 ПИРИДО[2,3-d]ПИРИМИДИН-2,7-ДИАМИНОВЫЕ ИНГИБИТОРЫ КИНАЗ

Country Status (34)

Country Link
EP (1) EP1254137A1 (is)
JP (1) JP4047010B2 (is)
KR (1) KR20020065939A (is)
CN (1) CN1395578A (is)
AP (1) AP2002002586A0 (is)
AR (1) AR030044A1 (is)
AU (1) AU2542501A (is)
BG (1) BG106850A (is)
BR (1) BR0107751A (is)
CA (1) CA2397961C (is)
CO (1) CO5261549A1 (is)
CR (1) CR6706A (is)
CZ (1) CZ20022475A3 (is)
DZ (1) DZ3266A1 (is)
EA (1) EA200200643A1 (is)
EE (1) EE200200405A (is)
GT (1) GT200100016A (is)
HN (1) HN2001000013A (is)
HU (1) HUP0204141A3 (is)
IL (1) IL150545A0 (is)
IS (1) IS6443A (is)
MA (1) MA26868A1 (is)
MX (1) MXPA02007221A (is)
NO (1) NO20023527L (is)
OA (1) OA12161A (is)
PA (1) PA8510701A1 (is)
PE (1) PE20011066A1 (is)
PL (1) PL356802A1 (is)
SK (1) SK10632002A3 (is)
SV (1) SV2002000294A (is)
TN (1) TNSN01014A1 (is)
WO (1) WO2001055147A1 (is)
YU (1) YU50402A (is)
ZA (1) ZA200205879B (is)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235551B2 (en) 2000-03-02 2007-06-26 Smithkline Beecham Corporation 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
CN1847229B (zh) 2000-10-23 2011-05-04 史密丝克莱恩比彻姆公司 2，4，8-三取代-8H-吡啶并[2，3-d]嘧啶-7-酮化合物
PE20030008A1 (es) * 2001-06-19 2003-01-22 Bristol Myers Squibb Co Inhibidores duales de pde 7 y pde 4
EP1499320B1 (en) 2002-04-19 2007-08-22 Smithkline Beecham Corporation Novel compounds
US7504410B2 (en) * 2002-11-28 2009-03-17 Schering Aktiengesellschaft Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
US7157455B2 (en) * 2003-02-10 2007-01-02 Hoffmann-La Roche Inc. 4-Aminopyrimidine-5-one derivatives
TW200502236A (en) * 2003-03-28 2005-01-16 Hoffmann La Roche Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
FR2873118B1 (fr) 2004-07-15 2007-11-23 Sanofi Synthelabo Derives de pyrido-pyrimidine, leur application en therapeutique
EP1794160A1 (en) * 2004-09-21 2007-06-13 F.Hoffmann-La Roche Ag 6-(2-alkyl-phenyl) - pyrido[2,3-d] pyrimidines useful as proteine kinase inhibitors
EP1868612A4 (en) 2005-03-25 2010-03-24 Glaxo Group Ltd NOVEL CONNECTIONS
PE20061193A1 (es) 2005-03-25 2006-12-02 Glaxo Group Ltd DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2-[1H]-0NA COMO INHIBIDORES DE QUINASA p38
UY29440A1 (es) 2005-03-25 2006-10-02 Glaxo Group Ltd Nuevos compuestos
CN101495475A (zh) 2005-03-25 2009-07-29 葛兰素集团有限公司 制备吡啶并[2,3-d]嘧啶-7-酮和3,4-二氢嘧啶并[4,5-d]嘧啶-2(1H)-酮衍生物的方法
FR2887882B1 (fr) 2005-07-01 2007-09-07 Sanofi Aventis Sa Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
CN101243081A (zh) * 2005-07-21 2008-08-13 霍夫曼-拉罗奇有限公司 作为PTP1B抑制剂的吡啶并[2,3-d]嘧啶-2,4-二胺化合物
BRPI0614804A2 (pt) * 2005-08-09 2011-04-12 Irm Llc compostos e composições como inibidores de proteìna cinase
FR2896246B1 (fr) 2006-01-13 2008-08-15 Sanofi Aventis Sa Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
EP1914234A1 (en) 2006-10-16 2008-04-23 GPC Biotech Inc. Pyrido[2,3-d]pyrimidines and their use as kinase inhibitors
JO2985B1 (ar) 2006-12-20 2016-09-05 Takeda Pharmaceuticals Co مثبطات كينازmapk/erk
FR2910813B1 (fr) * 2006-12-28 2009-02-06 Sanofi Aventis Sa Nouvelle utilisation therapeutique pour le traitement des leucemies
EP2112150B1 (en) 2008-04-22 2013-10-16 Forma Therapeutics, Inc. Improved raf inhibitors
EP2352732B1 (en) * 2008-12-01 2013-02-20 Merck Patent GmbH 2,5-DIAMINO-SUBSTITUTED PYRIDO[4, 3-d]PYRIMIDINES AS AUTOTAXIN INHIBITORS AGAINST CANCER
GB201104267D0 (en) 2011-03-14 2011-04-27 Cancer Rec Tech Ltd Pyrrolopyridineamino derivatives
GB201216018D0 (en) 2012-09-07 2012-10-24 Cancer Rec Tech Ltd Pharmacologically active compounds
GB201216017D0 (en) 2012-09-07 2012-10-24 Cancer Rec Tech Ltd Inhibitor compounds
ES2817448T3 (es) 2013-03-14 2021-04-07 Icahn School Med Mount Sinai Compuestos de pirimidina como inhibidores de quinasas
GB201403536D0 (en) 2014-02-28 2014-04-16 Cancer Rec Tech Ltd Inhibitor compounds
KR101671404B1 (ko) * 2014-09-02 2016-11-02 한국원자력의학원 항암 효과, 방사선 병용치료 효과 및 당뇨병 치료 효과를 갖는 피리미딘 유도체 및 이의 의학적 용도
CN107286180B (zh) * 2016-04-11 2019-07-02 上海勋和医药科技有限公司 杂代吡啶并嘧啶酮衍生物作为cdk抑制剂及其应用
GB201709840D0 (en) 2017-06-20 2017-08-02 Inst Of Cancer Research: Royal Cancer Hospital Methods and medical uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK281724B6 (sk) * 1994-11-14 2001-07-10 Warner-Lambert Company 6-arylpyrido[2,3-d]pyrimidíny, ich použitie a farmaceutické prostriedky na ich báze
IL115256A0 (en) * 1994-11-14 1995-12-31 Warner Lambert Co 6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
US5620981A (en) * 1995-05-03 1997-04-15 Warner-Lambert Company Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
KR20010043829A (ko) * 1998-05-26 2001-05-25 로즈 암스트롱, 크리스틴 에이. 트러트웨인 세포 증식 억제제로서의 비시클릭 피리미딘 및 비시클릭3,4-디히드로피리미딘

Also Published As

Publication number Publication date
OA12161A (en) 2006-05-08
PE20011066A1 (es) 2001-10-22
AP2002002586A0 (en) 2002-09-30
ZA200205879B (en) 2003-09-29
WO2001055147A1 (en) 2001-08-02
SV2002000294A (es) 2002-07-16
EP1254137A1 (en) 2002-11-06
YU50402A (sh) 2005-11-28
IS6443A (is) 2002-06-25
BG106850A (bg) 2003-02-28
GT200100016A (es) 2001-10-19
IL150545A0 (en) 2003-02-12
PL356802A1 (en) 2004-07-12
CN1395578A (zh) 2003-02-05
CA2397961C (en) 2008-08-26
NO20023527L (no) 2002-09-10
CA2397961A1 (en) 2001-08-02
CO5261549A1 (es) 2003-03-31
EE200200405A (et) 2003-12-15
MA26868A1 (fr) 2004-12-20
AU2542501A (en) 2001-08-07
DZ3266A1 (fr) 2001-08-02
AR030044A1 (es) 2003-08-13
JP2003523357A (ja) 2003-08-05
CR6706A (es) 2005-04-04
HN2001000013A (es) 2001-06-18
PA8510701A1 (es) 2002-12-11
NO20023527D0 (no) 2002-07-24
HUP0204141A2 (hu) 2003-04-28
JP4047010B2 (ja) 2008-02-13
HUP0204141A3 (en) 2005-03-29
SK10632002A3 (sk) 2003-06-03
KR20020065939A (ko) 2002-08-14
CZ20022475A3 (cs) 2003-03-12
BR0107751A (pt) 2002-11-12
TNSN01014A1 (fr) 2005-11-10
MXPA02007221A (es) 2002-11-29

Similar Documents

Publication Publication Date Title
EA200200643A1 (ru) ПИРИДО[2,3-d]ПИРИМИДИН-2,7-ДИАМИНОВЫЕ ИНГИБИТОРЫ КИНАЗ
EA200200802A1 (ru) 5-АЛКИЛПИРИДО[2.3-d]ПИРИМИДИНОВЫЕ ИНГИБИТОРЫ ТИРОЗИНКИНАЗЫ
EA200701991A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ИМИДАЗО [1,5-a]ПИРИДИНОВ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
ATE503483T1 (de) Hemmer der akt aktivität
IL256375A (en) New histological histories, process for their preparation and pharmaceutical preparations containing them
EA200000188A1 (ru) Производные 2,3-диарил-пиразоло[1,5-b]-пиридазинов, их получение и их применение в качестве ингибиторов циклооксигеназы-2 (цог-2)
EA201891463A1 (ru) ПРОИЗВОДНЫЕ ПИРАЗОЛО[1,5-a]ПИРАЗИН-4-ИЛА В КАЧЕСТВЕ ИНГИБИТОРОВ ЯНУС-КИНАЗЫ (JAK)
NO20082101L (no) Pyrido-, pyrazo- og pyrimido-pyrimidinderivater som mTor inhibitorer
AP2000001964A0 (en) Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation.
NZ533310A (en) Benzimidazoles useful as protein kinase inhibitors
WO2004096130A3 (en) Inhibitors of akt activity
RU2003122190A (ru) Производные тетрагидропиридина, их получение и применение в качестве ингибиторов клеточной пролиферации
HUP9801177A2 (hu) Tetrahidronaftil-, indanil- és indolilcsoporttal helyettesített pirido[2,3-d]pirimidin- és purinszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
EA200600973A1 (ru) ПИРИДО[2,3-d] ПИРИМИДИН-2,4-ДИАМИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ PDE 2
PE20020976A1 (es) Pirido-pirimidinas 6-sustituidas como inhibidores de quinasas
TR200401903T4 (tr) Raf kınaz tesir önleyici olarak imidazol-2-karboksamid türevleri.
HRP20030791B1 (en) DIHYDRO-BENZO[b][1,4]DIAZEPIN-2-ONE DERIVATIVES AS mGluR2 ANTAGONISTS I
KR880009019A (ko) 트리시클릭벤즈이미다졸, 이들의 제조방법 및 이들을 함유하는 약리학적 조성물
NZ599553A (en) Ethynyl derivatives
DE60214401D1 (de) Hetero-bicyclische crf antagonisten
ATE276257T1 (de) Pyrazinonderivate
FI964463A0 (fi) Bisykliset amidiinijohdannaiset typpioksidinsyntetaasin inhibiittoreina
RU2149000C1 (ru) Применение карбоциклически и гетероциклически анеллированных дигидропиридинов и их фармацевтически приемлемых солей в качестве блокатора неселективных каналов катионов при защите головного мозга и лечении хронической бронхиальной астмы
EA200100816A1 (ru) 2-аминопиридины, содержащие конденсированные кольца в качестве заместителей
WO2006044402A1 (en) Furazano `3, 4-b ! pyrazynes and their use as anti-tumor agents